OrthoPediatrics Corp Research and Development Expense
OrthoPediatrics Corp (KIDS) reported Research and Development Expense of $2.33 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05
- OrthoPediatrics Corp research and development expense for the quarter ending 2026-06-30 was $2.33M, a 7.69% increase year-over-year.
- OrthoPediatrics Corp research and development expense for the quarter ending 2026-03-31 was $2.23M, a 5.10% decline year-over-year.
- OrthoPediatrics Corp research and development expense for the quarter ending 2025-12-31 was $2.26M, a 22.53% decline year-over-year.
- OrthoPediatrics Corp research and development expense for the quarter ending 2025-09-30 was $2.33M, a 9.47% decline year-over-year.
- OrthoPediatrics Corp research and development expense for fiscal 2025 was $9.10M, a 17.51% decline from fiscal 2024.
- OrthoPediatrics Corp research and development expense for fiscal 2024 was $11.03M, a 1.28% increase from fiscal 2023.
- OrthoPediatrics Corp research and development expense for fiscal 2023 was $10.89M, a 28.90% increase from fiscal 2022.
- OrthoPediatrics Corp research and development expense for fiscal 2022 was $8.45M, a 52.48% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.33M 10-Q · filed 2026-08-05 | $4.56M 10-Q · filed 2026-08-05 | $6.82M derived: sum of 3 quarters · filed 2026-08-05 | $9.15M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $2.23M 10-Q · filed 2026-05-01 | $4.49M derived: sum of 2 quarters · filed 2026-05-01 | $6.82M derived: sum of 3 quarters · filed 2026-05-01 | $8.98M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $4.59M derived: sum of 2 quarters · filed 2026-03-04 | $6.75M derived: sum of 3 quarters · filed 2026-08-05 | $9.10M 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | $2.33M 10-Q · filed 2025-10-29 | $4.49M derived: sum of 2 quarters · filed 2026-08-05 | $6.84M 10-Q · filed 2025-10-29 | $9.76M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $2.16M 10-Q · filed 2026-08-05 | $4.51M 10-Q · filed 2026-08-05 | $7.43M derived: sum of 3 quarters · filed 2026-08-05 | $10.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $2.35M 10-Q · filed 2026-05-01 | $5.27M derived: sum of 2 quarters · filed 2026-05-01 | $7.84M derived: sum of 3 quarters · filed 2026-05-01 | $10.39M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $5.49M derived: sum of 2 quarters · filed 2026-03-04 | $8.04M derived: sum of 3 quarters · filed 2026-03-04 | $11.03M 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | $2.58M 10-Q · filed 2025-10-29 | $5.12M derived: sum of 2 quarters · filed 2025-10-29 | $8.12M 10-Q · filed 2025-10-29 | $11.04M derived: sum of 4 quarters · filed 2026-03-04 | ||||
| 2024-06-30 | $2.54M 10-Q · filed 2025-08-06 | $5.54M 10-Q · filed 2025-08-06 | $8.46M derived: sum of 3 quarters · filed 2026-03-04 | $11.02M derived: sum of 4 quarters · filed 2026-03-04 | ||||
| 2024-03-31 | $3.00M 10-Q · filed 2025-05-08 | $5.92M derived: sum of 2 quarters · filed 2026-03-04 | $8.48M derived: sum of 3 quarters · filed 2026-03-04 | $11.45M derived: sum of 4 quarters · filed 2026-03-04 | ||||
| 2023-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $5.48M derived: sum of 2 quarters · filed 2026-03-04 | $8.45M derived: sum of 3 quarters · filed 2026-03-04 | $10.89M 10-K · filed 2026-03-04 | $10.20M 10-K · filed 2024-03-08 | |||
| 2023-09-30 | $2.56M 10-Q · filed 2024-11-07 | $2.39M 10-Q · filed 2023-11-07 | $5.53M derived: sum of 2 quarters · filed 2024-11-07 | $7.97M 10-Q · filed 2024-11-07 | $7.45M 10-Q · filed 2023-11-07 | $10.45M derived: sum of 4 quarters · filed 2025-03-05 | ||
| 2023-06-30 | $2.97M 10-Q · filed 2024-08-06 | $2.79M 10-Q · filed 2023-08-01 | $5.41M 10-Q · filed 2024-08-06 | $5.06M 10-Q · filed 2023-08-01 | $7.88M derived: sum of 3 quarters · filed 2025-03-05 | $10.09M derived: sum of 4 quarters · filed 2025-03-05 | ||
| 2023-03-31 | $2.45M 10-Q · filed 2024-05-07 | $2.27M 10-Q · filed 2023-05-02 | $4.92M derived: sum of 2 quarters · filed 2025-03-05 | $7.12M derived: sum of 3 quarters · filed 2025-03-05 | $8.87M derived: sum of 4 quarters · filed 2025-03-05 | |||
| 2022-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $4.68M derived: sum of 2 quarters · filed 2025-03-05 | $6.42M derived: sum of 3 quarters · filed 2025-03-05 | $8.45M 10-K · filed 2025-03-05 | $8.01M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | $2.21M 10-Q · filed 2023-11-07 | $3.95M derived: sum of 2 quarters · filed 2023-11-07 | $5.98M 10-Q · filed 2023-11-07 | $7.59M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-06-30 | $1.75M 10-Q · filed 2023-08-01 | $3.77M 10-Q · filed 2023-08-01 | $5.38M derived: sum of 3 quarters · filed 2024-03-08 | $6.68M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-03-31 | $2.03M 10-Q · filed 2023-05-02 | $3.63M derived: sum of 2 quarters · filed 2024-03-08 | $4.94M derived: sum of 3 quarters · filed 2024-03-08 | $6.26M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $2.91M derived: sum of 2 quarters · filed 2024-03-08 | $4.24M derived: sum of 3 quarters · filed 2024-03-08 | $5.54M 10-K · filed 2024-03-08 | ||||
| 2021-09-30 | $1.30M 10-Q · filed 2022-11-01 | $2.63M derived: sum of 2 quarters · filed 2022-11-01 | $3.94M 10-Q · filed 2022-11-01 | $5.99M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $1.32M 10-Q · filed 2022-08-04 | $2.63M 10-Q · filed 2022-08-04 | $4.68M derived: sum of 3 quarters · filed 2023-03-01 | $5.76M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $1.31M 10-Q · filed 2022-05-05 | $3.36M derived: sum of 2 quarters · filed 2023-03-01 | $4.43M derived: sum of 3 quarters · filed 2023-03-01 | $5.32M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $3.13M derived: sum of 2 quarters · filed 2023-03-01 | $4.01M derived: sum of 3 quarters · filed 2023-03-01 | $5.27M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $1.08M 10-Q · filed 2021-11-04 | $1.96M derived: sum of 2 quarters · filed 2021-11-04 | $3.22M 10-Q · filed 2021-11-04 | $5.13M derived: sum of 4 quarters · filed 2022-03-03 | ||||
| 2020-06-30 | $881.00K 10-Q · filed 2021-08-05 | $2.15M 10-Q · filed 2021-08-05 | $4.05M derived: sum of 3 quarters · filed 2022-03-03 | $5.45M derived: sum of 4 quarters · filed 2022-03-03 | ||||
| 2020-03-31 | $1.26M 10-Q · filed 2021-05-06 | $3.17M derived: sum of 2 quarters · filed 2022-03-03 | $4.57M derived: sum of 3 quarters · filed 2022-03-03 | $5.80M derived: sum of 4 quarters · filed 2022-03-03 | ||||
| 2019-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $3.30M derived: sum of 2 quarters · filed 2022-03-03 | $4.54M derived: sum of 3 quarters · filed 2022-03-03 | $5.75M 10-K · filed 2022-03-03 | ||||
| 2019-09-30 | $1.40M 10-Q · filed 2020-11-05 | $2.63M derived: sum of 2 quarters · filed 2020-11-05 | $3.84M 10-Q · filed 2020-11-05 | $5.12M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-06-30 | $1.23M 10-Q · filed 2020-08-06 | $2.45M 10-Q · filed 2020-08-06 | $3.72M derived: sum of 3 quarters · filed 2021-03-11 | $4.85M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-03-31 | $1.21M 10-Q · filed 2020-05-06 | $2.49M derived: sum of 2 quarters · filed 2021-03-11 | $3.61M derived: sum of 3 quarters · filed 2021-03-11 | $4.73M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2018-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $2.40M derived: sum of 2 quarters · filed 2021-03-11 | $3.51M derived: sum of 3 quarters · filed 2021-03-11 | $4.73M 10-K · filed 2021-03-11 | ||||
| 2018-09-30 | $1.12M 10-Q · filed 2019-11-08 | $2.24M derived: sum of 2 quarters · filed 2019-11-08 | $3.46M 10-Q · filed 2019-11-08 | $4.40M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2018-06-30 | $1.11M 10-Q · filed 2019-08-13 | $2.33M 10-Q · filed 2019-08-13 | $3.27M derived: sum of 3 quarters · filed 2020-03-05 | $4.40M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2018-03-31 | $1.22M 10-Q · filed 2019-05-09 | $2.16M derived: sum of 2 quarters · filed 2020-03-05 | $3.29M derived: sum of 3 quarters · filed 2020-03-05 | $3.95M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2017-12-31 | $941.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $2.07M derived: sum of 2 quarters · filed 2020-03-05 | $2.74M derived: sum of 3 quarters · filed 2020-03-05 | $3.42M 10-K · filed 2020-03-05 | ||||
| 2017-09-30 | $1.13M 10-Q · filed 2018-10-31 | $1.79M derived: sum of 2 quarters · filed 2018-10-31 | $2.48M 10-Q · filed 2018-10-31 | $3.11M derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2017-06-30 | $668.00K 10-Q · filed 2018-08-09 | $1.35M 10-Q · filed 2018-08-09 | $1.98M derived: sum of 3 quarters · filed 2019-03-07 | $2.48M derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2017-03-31 | $687.00K 10-Q · filed 2018-05-15 | $1.31M derived: sum of 2 quarters · filed 2019-03-07 | $1.81M derived: sum of 3 quarters · filed 2019-03-07 | |||||
| 2016-12-31 | $624.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $1.13M derived: sum of 2 quarters · filed 2019-03-07 | $2.22M 10-K · filed 2019-03-07 | |||||
| 2016-09-30 | $501.00K 10-Q · filed 2017-11-13 | $1.60M 10-Q · filed 2017-11-13 | ||||||
| 2015-12-31 | $1.79M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |